CD8A and neoplasm: Avasimibe for example is an ACAT1 inhibitor, which prevents esterification of cholesterol and the attenuation of lipid rafts, which in turn increases the level of cholesterol in CD8+ T cells and promotes T cell receptor signal transduction, enhancing anti-tumour response (125).